2020
DOI: 10.1159/000505694
|View full text |Cite
|
Sign up to set email alerts
|

Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients

Abstract: Background: We aimed to evaluate the performance of a deep learning (DL)-based Radiomics strategy designed for analyzing contrast-enhanced ultrasound (CEUS) to not only predict the progression-free survival (PFS) of radiofrequency ablation (RFA) and surgical resection (SR) but also optimize the treatment selection between them for patients with very-early or earlystage hepatocellular carcinoma (HCC). Methods: We retrospectively enrolled 419 patients examined by CEUS within 1 week before receiving RFA or SR (RF… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
62
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(63 citation statements)
references
References 34 publications
0
62
0
1
Order By: Relevance
“…A more recent study, performed in 419 patients examined by CEUS within 1 week before receiving radiofrequency ablation or surgical resection (radiofrequency ablation: 214, surgical resection: 205), analyzed the CEUS findings and found that 17.3% of radiofrequency ablation patients and 27.3% of surgical resection patients should swap their treatment; as a result, their average probability of 2-year progression-free survival would increase by 12% and 15%, respectively [ 82 ]. Moreover, dynamic CEUS radiomics performed well (AUC 0.84) in predicting the post-ablation early recurrence of HCC [ 69 ].…”
Section: Radiomics-based Us For the Diagnosis Of Hccmentioning
confidence: 99%
“…A more recent study, performed in 419 patients examined by CEUS within 1 week before receiving radiofrequency ablation or surgical resection (radiofrequency ablation: 214, surgical resection: 205), analyzed the CEUS findings and found that 17.3% of radiofrequency ablation patients and 27.3% of surgical resection patients should swap their treatment; as a result, their average probability of 2-year progression-free survival would increase by 12% and 15%, respectively [ 82 ]. Moreover, dynamic CEUS radiomics performed well (AUC 0.84) in predicting the post-ablation early recurrence of HCC [ 69 ].…”
Section: Radiomics-based Us For the Diagnosis Of Hccmentioning
confidence: 99%
“…For the development of AI that determine the stage of liver fibrosis more accurately, Gatos et al reported a detection algorithm that excludes unreliable regions on SWE images, which contributes to a reduction in interobserver variability (45). Applying these AI models may be an alternative to invasive liver biopsy for (38) SVM, support vector machine; ANN, artificial neural network; CNN, convolutional neural network; CEUS, contrast-enhanced ultrasonography; HCC, hepatocellular carcinoma; AUC, area under the receiver operating characteristic curve; TACE, transarterial chemoembolization; RFA, radiofrequency ablation; C-index, concordance index.…”
Section: Ai-aided Diagnosis For Liver Tumors In Ultrasonographymentioning
confidence: 99%
“…They reported AUCs of 0.93 and 0.81 for the AI based on CEUS and B-mode US images, respectively, indicating a higher performance of the model pre-trained with CEUS images than that with B-mode US images. They also reported AI models for predicting outcomes in patients with HCC after two types of treatment—radiofrequency ablation (RFA) and liver resection—from radiomics information based on CEUS images ( 38 ). For the prediction of two-year progression-free survival (PFS), both models provided high prediction accuracy.…”
Section: Current Ai Models For Medical Imaging Of Liver Lesionsmentioning
confidence: 99%
“…This system achieved an average accuracy of 93.1%, when the 10-fold cross-validation strategy was employed. In [ 41 ], the authors assessed a radiomics methodology based on deep learning techniques to derive features in order to evaluate the Progression-Free Survival (PFS), as well as the Surgical Resection (SR) of the Radiofrequency Ablation (RFA) procedure. Another objective was that of optimizing the selection of patients with incipient HCC, supposed to undergo specific treatments.…”
Section: Introductionmentioning
confidence: 99%